# EDGAR Filing Document

**Accession Number:** 0000918541
**File Stem:** 0000918541-26-000033
**Filing Date:** 2026-5
**Character Count:** 120073
**Document Hash:** abab513ec98625dab1cb455ce87ca1b4
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000918541-26-000033.hdr.sgml**: 20260506

**ACCESSION NUMBER**: 0000918541-26-000033

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 91

**CONFORMED PERIOD OF REPORT**: 20260331

**FILED AS OF DATE**: 20260506

**DATE AS OF CHANGE**: 20260506

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** NN INC
- **CENTRAL INDEX KEY:** 0000918541
- **STANDARD INDUSTRIAL CLASSIFICATION:** METALWORKING MACHINERY & EQUIPMENT [3540]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 621096725
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39268
- **FILM NUMBER:** 26949791

**BUSINESS ADDRESS:**
- **STREET 1:** 6210 ARDREY KELL ROAD
- **STREET 2:** SUITE 120
- **CITY:** CHARLOTTE
- **STATE:** NC
- **ZIP:** 28277
- **BUSINESS PHONE:** 980-264-4300

**MAIL ADDRESS:**
- **STREET 1:** 6210 ARDREY KELL ROAD
- **STREET 2:** SUITE 120
- **CITY:** CHARLOTTE
- **STATE:** NC
- **ZIP:** 28277

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** NN BALL & ROLLER INC
- **DATE OF NAME CHANGE:** 19940203

?xml version='1.0' encoding='ASCII'? nnbr-20260331

 **&nbsp;&nbsp;&nbsp;&nbsp;UNITED STATES**

 **&nbsp;&nbsp;&nbsp;&nbsp;SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 10-Q**

☒ **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the quarterly period ended March 31, 2026**

**OR**

☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the transition period from <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u> to <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>**

**Commission File Number 001-39268**

![nnbrlogo.jpg](nnbr-20260331_g1.jpg)

**NN, Inc.**

**(Exact name of registrant as specified in its charter)**

---

| | |
|:---|:---|
| **Delaware** | **62-1096725** |
| *(State or other jurisdiction of<br>incorporation or organization)* | *(I.R.S. Employer<br>Identification No.)* |

---

**6210 Ardrey Kell Road, Suite 120**

**Charlotte, North Carolina 28277**

*(Address of principal executive offices, including zip code)*

**(980) 264-4300**

*(Registrant's telephone number, including area code)* 

---

| | | |
|:---|:---|:---|
| **Securities registered pursuant to Section 12(b) of the Act:** | **Securities registered pursuant to Section 12(b) of the Act:** | **Securities registered pursuant to Section 12(b) of the Act:** |
| *Title of each class* | *Trading symbol* | *Name of each exchange on which registered* |
| **Common Stock, par value $0.01** | **NNBR** | **The Nasdaq Stock Market LLC** |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.&nbsp;&nbsp;&nbsp;&nbsp;Yes ☒&nbsp;&nbsp;&nbsp;&nbsp;No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&nbsp;&nbsp;&nbsp;&nbsp;Yes ☒&nbsp;&nbsp;&nbsp;&nbsp;No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☐ | Accelerated filer | ☐ |
| Non-accelerated filer | ☒ | Smaller reporting company | ☒ |
| | | Emerging growth company | ☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&nbsp;&nbsp;&nbsp;&nbsp;Yes ☐&nbsp;&nbsp;&nbsp;&nbsp;No ☒

As of April 27, 2026, there were 52,773,512 shares of the registrant's common stock, par value $0.01 per share, outstanding.

------

<u>[**Table of Contents**](#ic208c3c52e35488b93bc4cab94d51b11_7)</u>

**NN, Inc.**

**INDEX**

---

| | | |
|:---|:---|:---|
| | | **Page** |
| <u>[PART I. FINANCIAL INFORMATION](#ic208c3c52e35488b93bc4cab94d51b11_10)</u> | <u>[PART I. FINANCIAL INFORMATION](#ic208c3c52e35488b93bc4cab94d51b11_10)</u> | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[3](#ic208c3c52e35488b93bc4cab94d51b11_10)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;Item 1. | &nbsp;&nbsp;<u>[Financial Statements](#ic208c3c52e35488b93bc4cab94d51b11_13)</u> | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[3](#ic208c3c52e35488b93bc4cab94d51b11_13)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;Item 2. | &nbsp;&nbsp;<u>[Management's Discussion and Analysis of Financial Condition and Results of Operations](#ic208c3c52e35488b93bc4cab94d51b11_115)</u> | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[20](#ic208c3c52e35488b93bc4cab94d51b11_115)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;Item 3. | &nbsp;&nbsp;<u>[Quantitative and Qualitative Disclosures About Market Risk](#ic208c3c52e35488b93bc4cab94d51b11_133)</u> | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[25](#ic208c3c52e35488b93bc4cab94d51b11_133)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;Item 4. | &nbsp;&nbsp;<u>[Controls and Procedures](#ic208c3c52e35488b93bc4cab94d51b11_136)</u> | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[26](#ic208c3c52e35488b93bc4cab94d51b11_136)</u> |
| <u>[PART II. OTHER INFORMATION](#ic208c3c52e35488b93bc4cab94d51b11_139)</u> | <u>[PART II. OTHER INFORMATION](#ic208c3c52e35488b93bc4cab94d51b11_139)</u> | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[27](#ic208c3c52e35488b93bc4cab94d51b11_139)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;Item 1. | &nbsp;&nbsp;<u>[Legal Proceedings](#ic208c3c52e35488b93bc4cab94d51b11_142)</u> | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[27](#ic208c3c52e35488b93bc4cab94d51b11_142)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;Item 1A. | &nbsp;&nbsp;<u>[Risk Factors](#ic208c3c52e35488b93bc4cab94d51b11_145)</u> | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[27](#ic208c3c52e35488b93bc4cab94d51b11_145)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;Item 2. | &nbsp;&nbsp;<u>[Unregistered Sales of Equity Securities and Use of Proceeds](#ic208c3c52e35488b93bc4cab94d51b11_148)</u> | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[27](#ic208c3c52e35488b93bc4cab94d51b11_148)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;Item 3. | &nbsp;&nbsp;<u>[Defaults Upon Senior Securities](#ic208c3c52e35488b93bc4cab94d51b11_154)</u> | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[27](#ic208c3c52e35488b93bc4cab94d51b11_154)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;Item 4. | &nbsp;&nbsp;<u>[Mine Safety Disclosures](#ic208c3c52e35488b93bc4cab94d51b11_157)</u> | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[27](#ic208c3c52e35488b93bc4cab94d51b11_157)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;Item 5. | &nbsp;&nbsp;<u>[Other Information](#ic208c3c52e35488b93bc4cab94d51b11_160)</u> | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[27](#ic208c3c52e35488b93bc4cab94d51b11_160)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;Item 6. | &nbsp;&nbsp;<u>[Exhibits](#ic208c3c52e35488b93bc4cab94d51b11_163)</u> | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[28](#ic208c3c52e35488b93bc4cab94d51b11_163)</u> |
| <u>[SIGNATURES](#ic208c3c52e35488b93bc4cab94d51b11_166)</u> | <u>[SIGNATURES](#ic208c3c52e35488b93bc4cab94d51b11_166)</u> | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[29](#ic208c3c52e35488b93bc4cab94d51b11_166)</u> |

---

------

<u>[**Table of Contents**](#ic208c3c52e35488b93bc4cab94d51b11_7)</u>

**PART I. FINANCIAL INFORMATION** 

**Item 1. &nbsp;&nbsp;&nbsp;&nbsp;Financial Statements**

**NN, Inc.**

**Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)** 

**(Unaudited)**

---

| | | |
|:---|:---|:---|
| | **Three Months Ended <br>March 31,** | **Three Months Ended <br>March 31,** |
| **(in thousands, except per share data)** | **2026** | **2025** |
| Net sales | $118452 | $105688 |
| Cost of sales (exclusive of depreciation and amortization shown separately below) | 99031 | 91646 |
| Selling, general, and administrative expense | 13294 | 11170 |
| Depreciation and amortization | 9240 | 8774 |
| Other operating income, net | (1055) | (1113) |
| **Loss from operations** | (2058) | (4789) |
| Interest expense | 5769 | 5194 |
| Other expense (income), net | 502 | (2169) |
| Loss before provision for income taxes and share of net income from joint venture | (8329) | (7814) |
| Provision for income taxes | (717) | (1310) |
| Share of net income from joint venture | 2218 | 2439 |
| **Net loss** | $(6828) | $(6685) |
| Other comprehensive income: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign currency translation gain | $1547 | $3125 |
| Other comprehensive income | $1547 | $3125 |
| **Comprehensive loss** | $(5281) | $(3560) |
| Basic and diluted net loss per share | $(0.25) | $(0.23) |
| Shares used to calculate basic and diluted net loss per share | 49702 | 49075 |

---

**See notes to condensed consolidated financial statements (unaudited).**

------

<u>[**Table of Contents**](#ic208c3c52e35488b93bc4cab94d51b11_7)</u>

**NN, Inc.**

**Condensed Consolidated Balance Sheets**

**(Unaudited)** 

---

| | | |
|:---|:---|:---|
| **(in thousands, except per share data)** | **March 31,<br>2026** | **December 31,<br>2025** |
| **Assets** | | |
| Current assets: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $8471 | $11377 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable, net of allowances of $1,496 and $1,401 at March 31, 2026 and December 31, 2025 | 71977 | 59785 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories | 68181 | 65978 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income tax receivable | 13622 | 13389 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepaid assets | 5375 | 2952 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other current assets | 12466 | 10526 |
| Total current assets | 180092 | 164007 |
| Property, plant and equipment, net of accumulated depreciation of $271,954 and $265,399 at March 31, 2026 and December 31, 2025 | 158369 | 158885 |
| Operating lease right-of-use assets | 33474 | 35155 |
| Intangible assets, net | 27384 | 30789 |
| Investment in joint venture | 45332 | 42543 |
| Deferred tax assets | 1673 | 1673 |
| Other non-current assets | 7102 | 7732 |
| Total assets | $453426 | $440784 |
| **Liabilities, Preferred Stock, and Stockholders' Equity** |  |  |
| Current liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | $51881 | $49442 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued salaries, wages and benefits | 17136 | 14004 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income tax payable | 323 | 553 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Current maturities of long-term debt | 3511 | 5791 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Current portion of operating lease liabilities | 5846 | 6430 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other current liabilities | 17826 | 13575 |
| Total current liabilities | 96523 | 89795 |
| Deferred tax liabilities | 4427 | 4312 |
| Long-term debt, net of current maturities | 166853 | 153758 |
| Operating lease liabilities, net of current portion | 35168 | 37092 |
| Other non-current liabilities | 6505 | 9420 |
| Total liabilities | 309476 | 294377 |
| Commitments and contingencies (Note 11) |  |  |
| Series D perpetual preferred stock - $0.01 par value per share, 65 shares authorized, issued and outstanding at March 31, 2026 and December 31, 2025 | 117847 | 112409 |
| Stockholders' equity: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Common stock - $0.01 par value per share, 90,000 shares authorized, 52,789 and 50,196 shares issued and outstanding at March 31, 2026 and December 31, 2025 | 527 | 502 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Additional paid-in capital | 437061 | 439700 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accumulated deficit | (374453) | (367625) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accumulated other comprehensive loss | (37032) | (38579) |
| Total stockholders' equity | 26103 | 33998 |
| Total liabilities, preferred stock, and stockholders' equity | $453426 | $440784 |

---

**See notes to condensed consolidated financial statements (unaudited).**

------

<u>[**Table of Contents**](#ic208c3c52e35488b93bc4cab94d51b11_7)</u>

**NN, Inc.**

**Condensed Consolidated Statements of Cash Flows** 

**(Unaudited)**

---

| | | |
|:---|:---|:---|
| | **Three Months Ended <br>March 31,** | **Three Months Ended <br>March 31,** |
| **(in thousands)** | **2026** | **2025** |
| **Cash flows from operating activities** |  |  |
| Net loss | $(6828) | $(6685) |
| Adjustments to reconcile net loss to net cash used in operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 9240 | 8774 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of debt issuance costs and discount | 249 | 716 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Paid-in-kind interest | 1542 | 316 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total derivative loss (gain), net of cash settlements | 245 | (1762) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Share of net income from joint venture | (2218) | (2439) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Share-based compensation expense | 801 | 839 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred income taxes | 179 | 174 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other | (196) | (519) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Changes in operating assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable | (12011) | (5403) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories | (1919) | (220) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other operating assets | (4479) | (3444) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income taxes receivable and payable, net | (457) | (163) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | 578 | 6468 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other operating liabilities | 6653 | 3 |
| Net cash used in operating activities | (8621) | (3345) |
| **Cash flows from investing activities** |  |  |
| Acquisition of property, plant and equipment | (3297) | (3907) |
| Proceeds from sale of property, plant, and equipment | 100 | 177 |
| Net cash used in investing activities | (3197) | (3730) |
| **Cash flows from financing activities** |  |  |
| Proceeds from asset backed credit facilities | 16200 | 11000 |
| Repayments of asset backed credit facilities | (15950) | (9026) |
| Proceeds from long-term debt | 10000 |  |
| Repayments long-term debt | (284) |  |
| Cash paid for debt issuance costs | (100) |  |
| Repayments of financing obligations | (465) | (297) |
| Other | (1444) | (1094) |
| Net cash provided by financing activities | 7957 | 583 |
| Effect of exchange rate changes on cash flows | 955 | 103 |
| Net change in cash and cash equivalents | (2906) | (6389) |
| Cash and cash equivalents at beginning of period | 11377 | 18128 |
| Cash and cash equivalents at end of period | $8471 | $11739 |

---

**See notes to condensed consolidated financial statements (unaudited).**

------

<u>[**Table of Contents**](#ic208c3c52e35488b93bc4cab94d51b11_7)</u>

**NN, Inc.**

**Condensed Consolidated Statements of Changes in Stockholders' Equity** 

**Three Months Ended March 31, 2026 and 2025** 

**(Unaudited)** 

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Common Stock** | **Common Stock** | **Additional<br>paid-in<br>capital** | **Accumulated deficit** | **Accumulated other comprehensive loss** | **Total** |
| **(in thousands)** | **Number of shares** | **Par<br>value** | **Additional<br>paid-in<br>capital** | **Accumulated deficit** | **Accumulated other comprehensive loss** | **Total** |
| Balance as of December 31, 2025 | 50196 | $502 | $439700 | $(367625) | $(38579) | $33998 |
| &nbsp;&nbsp;&nbsp;Net loss |  |  |  | (6828) |  | (6828) |
| &nbsp;&nbsp;&nbsp;Dividends accrued for preferred stock |  |  | (5438) |  |  | (5438) |
| &nbsp;&nbsp;&nbsp;Shares issued for warrants exercised | 1455 | 14 | 2095 |  |  | 2109 |
| &nbsp;&nbsp;&nbsp;Shares issued under stock incentive plans, net of forfeitures and tax withholdings | 1206 | 12 | (12) |  |  |  |
| &nbsp;&nbsp;&nbsp;Share-based compensation expense |  |  | 801 |  |  | 801 |
| &nbsp;&nbsp;&nbsp;Restricted shares surrendered for tax withholdings under stock incentive plans | (68) | (1) | (85) |  |  | (86) |
| &nbsp;&nbsp;&nbsp;Other comprehensive income |  |  |  |  | 1547 | 1547 |
| Balance as of March 31, 2026 | 52789 | $527 | $437061 | $(374453) | $(37032) | $26103 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Common Stock** | **Common Stock** | **Additional<br>paid-in<br>capital** | **Accumulated deficit** | **Accumulated other comprehensive loss** | **Total** |
| **(in thousands)** | **Number of shares** | **Par<br>value** | **Additional<br>paid-in<br>capital** | **Accumulated deficit** | **Accumulated other comprehensive loss** | **Total** |
| Balance as of December 31, 2024 | 49908 | $499 | $455811 | $(333621) | $(48167) | $74522 |
| &nbsp;&nbsp;&nbsp;Net loss |  |  |  | (6685) |  | (6685) |
| &nbsp;&nbsp;&nbsp;Dividends accrued for preferred stock |  |  | (4407) |  |  | (4407) |
| &nbsp;&nbsp;&nbsp;Shares issued under stock incentive plans, net of forfeitures and tax withholdings | 637 | 6 | (7) |  |  | (1) |
| &nbsp;&nbsp;&nbsp;Share-based compensation expense |  |  | 839 |  |  | 839 |
| &nbsp;&nbsp;&nbsp;Restricted shares surrendered for tax withholdings under stock incentive plans | (19) |  | (49) |  |  | (49) |
| &nbsp;&nbsp;&nbsp;Other comprehensive income |  |  |  |  | 3125 | 3125 |
| Balance as of March 31, 2025 | 50526 | $505 | $452187 | $(340306) | $(45042) | $67344 |

---

**See notes to condensed consolidated financial statements (unaudited).**

------

<u>[**Table of Contents**](#ic208c3c52e35488b93bc4cab94d51b11_7)</u>

**NN, Inc.**

**Notes to Condensed Consolidated Financial Statements** 

**March 31, 2026**

**(Unaudited)**

**Note 1. Interim Financial Statements** 

*Nature of Business*

NN, Inc., a Delaware corporation, is a diversified industrial company that combines advanced engineering and production capabilities with in-depth materials science expertise to design and manufacture high-precision components and assemblies for a variety of end markets on a global basis. As of March 31, 2026, we had 27 facilities in North America, South America, Europe and China. As used in this Quarterly Report on Form 10-Q (this "Quarterly Report"), the terms "NN," the "Company," "we," "our," or "us" refer to NN, Inc. and its subsidiaries.

*Basis of Presentation*

The accompanying condensed consolidated financial statements have not been audited. The Condensed Consolidated Balance Sheet as of December 31, 2025, was derived from the audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2025 (the "2025 Annual Report"), which we filed with the U.S. Securities and Exchange Commission (the "SEC") on March 4, 2026. In management's opinion, the accompanying unaudited condensed consolidated financial statements reflect all adjustments necessary to fairly state our results of operations for the three months ended March 31, 2026 and 2025; financial position as of March 31, 2026 and December 31, 2025; and cash flows for the three months ended March 31, 2026 and 2025, on a basis consistent with our audited consolidated financial statements. These adjustments are of a normal recurring nature and are, in the opinion of management, necessary to state fairly our financial position and operating results for the interim periods. Certain prior period amounts have been reclassified to conform to the current year's presentation.

Certain information and footnote disclosures normally included in the consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States ("U.S. GAAP") have been condensed or omitted from the unaudited condensed consolidated financial statements presented in this Quarterly Report. These unaudited condensed consolidated financial statements should be read in conjunction with our audited consolidated financial statements and accompanying notes included in the 2025 Annual Report. The results for the three months ended March 31, 2026, are not necessarily indicative of results for the year ending December 31, 2026, or any other future periods.

Except for per share data or as otherwise indicated, all U.S. dollar amounts and share counts presented in the tables in these Notes to Condensed Consolidated Financial Statements are in thousands.

*Accounting Standards Recently Adopted*

In December 2023, the FASB issued ASU 2023-09, "*Income Taxes (Topic 740): Improvements to Income Tax Disclosures*" ("ASU 2023-09"), which requires additional annual income tax disclosures. These include a tabular rate reconciliation comprised of eight specific categories, the disaggregation of income taxes paid between federal, state, and foreign jurisdictions, and to disaggregate income from continuing operations before income tax expense and income tax expense from continuing operations between domestic and foreign. ASU 2023-09 eliminates the disclosure of the nature and estimate of reasonably possible changes to unrecognized tax benefits in the next 12 months or that an estimated range cannot be made. We adopted ASU 2023-09 for the year ended December 31, 2025 and have presented the required interim disclosures on a retrospective basis in this Quarterly Report on Form 10-Q.

In July 2025, the FASB issued ASU 2025-05, *"Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets"* ("ASU 2025-05"), which simplifies how entities measure expected credit losses on current accounts receivable and current contract assets arising from transactions accounted for under ASC 606. This update provides a practical expedient that allows entities to assume that current conditions as of the balance sheet date will remain unchanged for the remaining life of the asset when estimating credit losses. ASU 2025-05 became effective for fiscal years beginning on or after December 15, 2025. We have adopted the practical expedient effective for the current fiscal year noting that it does not have a material impact on the Company's financial statements.

*Accounting Standards Not Yet Adopted*

In November 2024, the FASB issued ASU 2024-03, "*Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses*" ("ASU 2024-03"), which requires disaggregated disclosures of certain categories of expenses that are included in income statement line items. ASU 2024-03 is effective for fiscal years beginning on or after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027. Companies may early adopt and can apply the guidance prospectively or retrospectively. We have not yet determined the potential impact of adopting this standard.

------

<u>[**Table of Contents**](#ic208c3c52e35488b93bc4cab94d51b11_7)</u>

*Assets Held for Sale*

During the year ended December 31, 2025, we ceased production activity at our Mobile Solutions plant in Dowagiac, Michigan. The assets that we own have been classified as held for sale as of March 31, 2026 as we are actively marketing the property and equipment for sale. The net book value of remaining assets held for sale of $1.0 million is included in Other current assets on the Condensed Consolidated Balance Sheets as of March 31, 2026.

**Note 2. Segment Information** 

Our business is aggregated into the following two reportable segments:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Mobile Solutions, which is focused on growth in the automotive, general industrial, and medical end markets; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Power Solutions, which is focused on growth in the electrical, general industrial, automotive, and medical end markets.

These reportable segments are considered our two operating segments as each has engaged in business activities for which it earns revenues and incurs expenses, discrete financial information is available for each, and this is the level at which the chief operating decision maker ("CODM") reviews discrete financial information for purposes of allocating resources and assessing performance. The CODM, who is our President and Chief Executive Officer, uses segment operating income (loss) to evaluate the performance of our segments each quarter and for annual forecasting purposes. Segment operating income (loss) is used to make key operating decisions, such as the amount and timing of capital expenditures, plant optimization actions, and allocation of management resources. In addition to our two reportable segments, we report a Corporate category, which includes corporate costs and unallocated expenses. Accounting for transactions between segments are recorded at cost.

The following tables reconcile segment net sales to consolidated loss before provision for income taxes and share of net income from joint venture.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **<u>Three Months Ended March 31, 2026</u>** | **Mobile<br>Solutions** | **Power<br>Solutions** | **Corporate and Eliminations** | **Total** |
| Net sales | $63113 | $55400 | $(61) | $118452 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cost of sales | 55633 | 43469 | (71) | 99031 |
| &nbsp;&nbsp;&nbsp;&nbsp;Selling, general, and administrative expense | 4136 | 3043 | 6115 | 13294 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation expense | 4663 | 800 | 372 | 5835 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other segment items (1) | 756 | 1791 | (197) | 2350 |
| Segment operating (loss) income | $(2075) | $6297 | $(6280) | $(2058) |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense |  |  |  | 5769 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other expense, net |  |  |  | 502 |
| Loss before provision for income taxes and share of net income from joint venture |  |  |  | $(8329) |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **<u>Three Months Ended March 31, 2025</u>** | **Mobile<br>Solutions** | **Power<br>Solutions** | **Corporate and Eliminations** | **Total** |
| Net sales | $62244 | $43508 | (64) | $105688 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cost of sales | 56450 | 35268 | (72) | 91646 |
| &nbsp;&nbsp;&nbsp;&nbsp;Selling, general, and administrative expense | 3538 | 2682 | 4950 | 11170 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation expense | 4209 | 780 | 380 | 5369 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other segment items (1) | 734 | 1755 | (197) | 2292 |
| Segment operating (loss) income | $(2687) | $3023 | $(5125) | $(4789) |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense |  |  |  | 5194 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other income, net |  |  |  | (2169) |
| Loss before provision for income taxes and share of net income from joint venture |  |  |  | $(7814) |

---

(1) Other segment items includes amortization expense and other operating expenses and income.

------

<u>[**Table of Contents**](#ic208c3c52e35488b93bc4cab94d51b11_7)</u>

The following table presents capital expenditures and depreciation and amortization by reportable segment.

---

| | | |
|:---|:---|:---|
| | **Three Months Ended <br>March 31,** | **Three Months Ended <br>March 31,** |
| | **2026** | **2025** |
| Capital expenditures: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Mobile Solutions | $2911 | $2666 |
| &nbsp;&nbsp;&nbsp;&nbsp;Power Solutions | 202 | 874 |
| &nbsp;&nbsp;&nbsp;&nbsp;Corporate | 184 | 367 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | $3297 | $3907 |
| Depreciation and amortization: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Mobile Solutions | $5501 | $5047 |
| &nbsp;&nbsp;&nbsp;&nbsp;Power Solutions | 3367 | 3347 |
| &nbsp;&nbsp;&nbsp;&nbsp;Corporate | 372 | 380 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | $9240 | $8774 |

---

The following table summarizes total assets by reportable segment.

---

| | | |
|:---|:---|:---|
| | **March 31, 2026** | **December 31, 2025** |
| Mobile Solutions (1) | $292879 | $287974 |
| Power Solutions | 129044 | 123883 |
| Corporate | 31503 | 28927 |
| Total | $453426 | $440784 |

---

_______________________________

&nbsp;&nbsp;&nbsp;&nbsp;(1) &nbsp;&nbsp;&nbsp;&nbsp;Total assets in Mobile Solutions includes $45.3 million and $42.5 million as of March 31, 2026 and December 31, 2025, respectively, related to our investment in a joint venture (see Note 7).

**Note 3. Revenue from Contracts with Customers**

Revenue is recognized when control of the good or service is transferred to the customer either at a point in time or, in limited circumstances, as our services are rendered over time. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring goods or services.

The following tables summarize revenue by customer industry. Our products in the automotive and commercial vehicle industry include high-precision components and assemblies for electric power steering systems, electric braking, electric motors, fuel systems, emissions control, transmissions, stampings, sensors, and electrical contacts. Our products in the general industrial industry include high-precision metal components for a variety of industrial applications including diesel industrial motors, heating and cooling systems, fluid power systems, power tools, and more. While many of the industries we serve include electrical components, our products in the residential/commercial electrical industry category in the following tables include components used in smart meters, charging stations, circuit breakers, transformers, electrical contact assemblies, precision stampings, welded contact assemblies, specification plating, and surface finishing. The other category includes products sold in aerospace, defense, medical, and other industries.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **<u>Three Months Ended March 31, 2026</u>** | **Mobile<br>Solutions** | **Power<br>Solutions** | **Intersegment<br>Sales<br>Eliminations** | **Total** |
| Automotive and Commercial Vehicle | $55083 | $8148 | $— | $63231 |
| General Industrial | 1322 | 14665 |  | 15987 |
| Residential/Commercial Electrical |  | 25233 |  | 25233 |
| Other | 6708 | 7354 | (61) | 14001 |
| Total net sales | $63113 | $55400 | $(61) | $118452 |

---

------

<u>[**Table of Contents**](#ic208c3c52e35488b93bc4cab94d51b11_7)</u>

---

| | | | | |
|:---|:---|:---|:---|:---|
| **<u>Three Months Ended March 31, 2025</u>** | **Mobile<br>Solutions** | **Power<br>Solutions** | **Intersegment<br>Sales<br>Eliminations** | **Total** |
| Automotive and Commercial Vehicle | $52887 | $7237 | $— | $60124 |
| General Industrial | 4403 | 9579 |  | 13982 |
| Residential/Commercial Electrical |  | 20532 |  | 20532 |
| Other | 4954 | 6160 | (64) | 11050 |
| Total net sales | $62244 | $43508 | $(64) | $105688 |

---

*Sales Concentration* 

During the three months ended March 31, 2026, a customer in our Mobile Solutions segment represented 11% of consolidated revenue. During the three months ended March 31, 2025, a customer in our Mobile Solutions segment represented 13% of consolidated revenue, and a customer from our Power Solutions segment represented 11% of consolidated revenue.

*Deferred Revenue*

Deferred revenue relates to payments received in advance of performance under the contract and recognized as revenue as (or when) we perform under the contract. The balance of deferred revenue was $0.5 million and $0.3 million as of March 31, 2026 and December 31, 2025, respectively. Revenue recognized for performance obligations satisfied or partially satisfied during the three months ended March 31, 2026 included $0.1 million that was included in deferred revenue as of December 31, 2025. The balance of deferred revenue was $0.4 million and $0.2 million as of March 31, 2025 and December 31, 2024, respectively. Revenue recognized for performance obligations satisfied or partially satisfied during the three months ended March 31, 2025 included $0.1 million that was included in deferred revenue as of December 31, 2024.

*Transaction Price Allocated to Future Performance Obligations*

We are required to disclose the aggregate amount of transaction price that is allocated to performance obligations that have not yet been satisfied as of March 31, 2026, unless our contracts meet one of the practical expedients. Our contracts met the practical expedient for a performance obligation that is part of a contract that has an original expected duration of one year or less.

**Note 4. Accounts Receivable**

The balance of trade accounts receivable was $67.8 million and $61.5 million as of March 31, 2025 and December 31, 2024, respectively. The following table presents changes in the allowance for credit losses.

---

| | | |
|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** |
| | **March 31, 2026** | **March 31, 2025** |
| Balance at beginning of period | 1401 | $1515 |
| Additions | 49 | (72) |
| Write-offs and other | 49 | (81) |
| Currency impact | (3) | 13 |
| Balance at end of period | $1496 | $1375 |

---

As of March 31, 2026, one customer represented 12% of consolidated accounts receivable. Amounts due from this customer are primarily related to Mobile Solutions.

We participate in programs that allow us to sell certain receivables from customers on a non-recourse basis to third-party financial institutions. During the three months ended March 31, 2026 and 2025, we incurred fees of $0.2 million and $0.1 million, respectively, related to the sale of receivables, which is recorded in the Other expense (income), net line item on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss).

------

<u>[**Table of Contents**](#ic208c3c52e35488b93bc4cab94d51b11_7)</u>

**Note 5. Inventories** 

Inventories are comprised of the following amounts:

---

| | | |
|:---|:---|:---|
| | **March 31, 2026** | **December 31, 2025** |
| Raw materials | $25991 | $26528 |
| Work in process | 22101 | 19739 |
| Finished goods | 20089 | 19711 |
| &nbsp;&nbsp;&nbsp;Total inventories | $68181 | $65978 |

---

**Note 6. Intangible Assets** 

The following table shows changes in the carrying amount of intangible assets, net, by reportable segment.

---

| | | | |
|:---|:---|:---|:---|
| | **Mobile<br>Solutions** | **Power<br>Solutions** | **Total** |
| Balance as of December 31, 2025 | $12296 | $18493 | $30789 |
| Amortization | (838) | (2567) | (3405) |
| Balance as of March 31, 2026 | $11458 | $15926 | $27384 |

---

Intangible assets are reviewed for impairment when changes in circumstances indicate the carrying value of those assets may not be recoverable. There were no impairment charges for the three months ended March 31, 2026 and 2025.

**Note 7. Investment in Joint Venture** 

We own a 49% investment in Wuxi Weifu Autocam Precision Machinery Company, Ltd. (the "JV"), a joint venture located in Wuxi, China. The JV is jointly controlled and managed, and we account for it under the equity method, with the share of net income from the joint venture recorded in the Mobile Solutions segment.

The following table shows changes in our investment in the JV.

---

| | |
|:---|:---|
| Balance as of December 31, 2025 | $42543 |
| Share of earnings | 2218 |
| Foreign currency translation gain | 571 |
| Balance as of March 31, 2026 | $45332 |

---

**Note 8. Debt** 

The following table presents amounts outstanding on our debt facilities.

---

| | | |
|:---|:---|:---|
| | **March 31, 2026** | **December 31, 2025** |
| Term loan facilities | $131810 | $120289 |
| ABL Facility | 4950 | 4700 |
| Financing obligations from sale-leaseback transactions | 29777 | 30213 |
| International loans | 7534 | 8148 |
| Unamortized debt issuance costs and discount (1) | (3707) | (3801) |
| &nbsp;&nbsp;&nbsp;Total debt | $170364 | $159549 |

---

_______________________________

&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;&nbsp;&nbsp;&nbsp;In addition to this amount, costs of $0.8 million and $0.9 million related to the ABL Facility (as defined below) were recorded in other non-current assets as of March 31, 2026 and December 31, 2025, respectively.

We capitalized interest costs of $0.2 million and $0.2 million in the three months ended March 31, 2026 and 2025, respectively, related to construction in progress.

*Term Loan Facility*

On April 16, 2025 (the "Closing Date"), we entered into a Term Loan Credit Agreement by and among the Company, the lenders from time to time party thereto (collectively, the "Lenders") and Alter Domus (US) LLC, as administrative agent (the "Term Loan Agent") for the Lenders (the "Term Loan Credit Agreement"). The Term Loan Credit Agreement establishes a new $128.0 million senior secured Term Loan Facility (the "Term Loan Facility") consisting of (i) a $118.0 million of term loan funded in full on the Closing Date (the "Closing Date Term Loans") and (ii) $10.0 million of delayed draw term loan commitments (any delayed draw term loans funded thereunder, the "Delayed Draw Term Loans", and together, with the Closing Date Term Loans, the "Term Loans"). As of March 31, 2026, we had $11.4 million of outstanding letters of credit issued under the ABL Facility and $30.7 million in undrawn commitments. The Term Loans mature on April 16, 2030. We

------

<u>[**Table of Contents**](#ic208c3c52e35488b93bc4cab94d51b11_7)</u>

used the proceeds from the Closing Date Term Loan to repay all of our outstanding obligations under our outstanding term loan facility (*see "2021 Term Loan" below*).

Under the Term Loan Credit Agreement, interest rates on the Term Loans are determined based on the type of Term Loan, the length of the interest period, our Consolidated Net Leverage Ratio (as defined in the Term Loan Credit Agreement). The Term Loans currently bear interest at either: 1) one-month, three-month, or six-month term secured overnight finance rate ("SOFR") with a credit spread adjustment, subject to a 2.00% floor, plus an applicable margin ranging from 8.75% to 9.75% based on our Consolidated Net Leverage Ratio (as defined herein) ("Adjusted Term SOFR Rate Loans"); or 2) the greater of various benchmark rates, with certain adjustments, plus an applicable margin ranging from 7.75% to 8.75% based on our Consolidated Net Leverage Ratio ("Base Rate Loans"). For interest payments due before April 16, 2027, we may elect to pay a portion of interest in-kind ("PIK Election"), subject to a minimum cash interest of 5.25% for Adjusted Term SOFR Rate Loans and 4.25% for Base Rate Loans. The applicable margin increases by 0.50% on borrowings to which the PIK Election is made. At March 31, 2026, the Term Loans bore interest, including amounts we have elected to pay as PIK interest, based on one-month Adjusted Term SOFR, at 13.52%.

On January 29, 2026, we borrowed $10.0 million on the Delayed Draw Term Loans. As a result of borrowing the Delayed Draw Term Loans, the applicable margin for all Term Loans increased by 0.50%. Through January 29, 2026, we incurred a 1.00% commitment fee on undrawn amounts under the Delayed Draw, payable quarterly in arrears.

Subject to certain exceptions, we are required to make principal payments (i) annually that are calculated as a percentage, based on our Consolidated Net Leverage Ratio, of our Excess Cash Flow (as defined in the Term Loan Credit Agreement), (ii) Net Cash Proceeds (as defined in the Term Loan Credit Agreement) of certain non-ordinary course Dispositions (as defined in the Term Loan Credit Agreement) within 10 business days of receipt thereof, and (iii) Net Cash Proceeds from certain insurance events. We may voluntarily prepay the Term Loans, in whole or part without premium or penalty following April 16, 2027. If we would have voluntarily prepaid borrowings prior to April 16, 2026, we would have been subject to a prepayment premium equal to the present value at the prepayment date of (i) 2.00% of the outstanding principal amount of the Term Loans to be prepaid, plus (ii) all remaining scheduled interest payments due on such Term Loans through April 16, 2026 (excluding accrued but unpaid interest to, but not including, the prepayment date), computed using a discount rate equal to the Treasury Rate (determined as of the Business Day prior to such date of prepayment) plus 50 basis points. If we voluntarily prepay borrowings following April 16, 2026 and prior to April 16, 2027, we are subject to a prepayment premium equal to 2.00% of the principal amount prepaid.

The Term Loan Credit Agreement includes customary representations, warranties and covenants, including, but not limited to, certain financial covenants, such as maximum Consolidated Net Leverage Ratio and minimum Domestic Liquidity (as defined in the Term Loan Credit Agreement), subject, in the case of the Consolidated Net Leverage Ratio covenant, to certain equity cure rights. We were in compliance with the financial covenants of the Term Loan Facility as of March 31, 2026.

Our obligations under the Term Loan Credit Agreement are guaranteed by certain of our subsidiaries and are required to be guaranteed by certain of our later formed or acquired subsidiaries (collectively, the "Guarantors"). Our obligations under the Term Loan Credit Agreement are collateralized by substantially all of our and the Guarantors' assets. The Term Loan Agent, for itself and on behalf of the Lenders, has a first lien on all domestic assets, other than accounts receivable and inventory, and certain foreign assets and has a second lien on domestic accounts receivable and inventory.

The Term Loan Credit Agreement contains customary events of default relating to, among other things, payment defaults, breach of covenants, cross acceleration to material indebtedness, bankruptcy-related defaults, judgment defaults, and the occurrence of certain change of control events. If an event of default occurs, the lenders under the Term Loan Credit Agreement will be entitled to take various actions, including the termination of any undrawn commitments and the acceleration of amounts due under the Term Loan Credit Agreement.

The Term Loan Facility was issued at a $2.5 million discount and we capitalized an additional $0.7 million in debt issuance costs. In January 2026, we capitalized an additional $0.1 million in debt issuance costs as part of the borrowings under the Delayed Draw Term Loan. These costs are recorded as a direct reduction to the carrying amount of the associated long-term debt and amortized over the term of the debt.

*2021 Term Loan*

On March 22, 2021, we entered into a $150.0 million term loan facility (as amended from time to time, the "2021 Term Loan Facility") which required principal payments of $0.4 million with the remaining unpaid principal amount due at the original loan maturity date of September 22, 2026. On April 16, 2025, we repaid all of our outstanding obligations under the 2021 Term Loan Facility with the proceeds from the Closing Date Term Loans. The 2021 Term Loan Facility was collateralized by all of our assets and had a first lien on all domestic assets, other than accounts receivable and inventory and had a second lien on

------

<u>[**Table of Contents**](#ic208c3c52e35488b93bc4cab94d51b11_7)</u>

domestic accounts receivable and inventory.

Outstanding borrowings on the 2021 Term Loan bore interest at either: 1) one-month, three-month, or six-month term secured overnight finance rate ("SOFR") with a duration adjustment ("Adjusted Term SOFR"), subject to a 1.000% floor, plus an applicable margin of 6.875%, or 2) the greater of various benchmark rates plus an applicable margin of 5.875%. Beginning in the second quarter of 2023, interest was increased on a paid-in-kind basis at a rate between 1.00% and 2.00% ("PIK interest"), dependent on our net leverage ratio for the most recently reported fiscal quarter and subject to reduction upon the occurrence of certain conditions as set forth in the credit agreement governing the 2021 Term Loan Facility. At April 16, 2025, the 2021 Term Loan Facility bore interest, including PIK interest, based on one-month Adjusted Term SOFR, at 12.30%.

The 2021 Term Loan Facility was issued at a $3.8 million discount and we capitalized an additional $5.5 million in debt issuance costs which were amortized over the term of the debt.

During the year ended December 31, 2025, we recognized a $3.0 million loss on extinguishment in connection with the termination of the 2021 Term Loan Facility.

*ABL Facility*

On December 30, 2024, we entered into a Revolving Credit and Security Agreement by and among the Company and PNC Bank National Association as lender and administrative agent (in such capacity, the "ABL Agent") (as amended from time to time, including by the First Amendment to Revolving Credit and Security Agreement, dated as of April 16, 2025, the "ABL Credit Agreement"). The ABL Credit Agreement established a new $50 million senior secured asset backed credit facility (the "ABL Facility") which provides for senior secured revolving loans ("Revolving Loan") in the amount of $50.0 million, and permits the issuance of letters of credit thereunder subject to a $15.0 million sublimit. The availability under the ABL Facility is limited by a borrowing base calculation derived from accounts receivable and inventory held in the United States, less customary reserves and other items. The final maturity date of the ABL Facility is the earlier of: 1) December 30, 2029; or 2) 91 days prior to the loan maturity date of the Term Loan Facility.

Under the ABL Facility, Revolving Loans bear interest as either 1) one, three or six month SOFR plus 1.50%, plus an adjustment of 0.10% ("Term SOFR Rate"); or 2) the highest of the base commercial lending rate of the lender or various benchmark rates plus an applicable margin of 0.50% or 1.00%, depending on the benchmark ("Alternative Base Rate"). At March 31, 2026, based on a Alternative Base Rate, the interest rate on outstanding borrowings under the ABL Facility was 7.25%. We incur a commitment fee of 0.25% for unused capacity under the ABL Facility and a 1.85% fee on the amount of letters of credit outstanding. The final maturity date of the ABL Facility is the earlier of: 1) December 30, 2029; or 2) 91 days prior to the loan maturity date of the Term Loan Facility. We capitalized a total of $1.2 million in new debt issuance costs related to the ABL Facility.

As of March 31, 2026, we had $5.0 million outstanding borrowings under the ABL Facility, $11.4 million of outstanding letters of credit, and $30.7 million available for future borrowings under the ABL Facility.

The ABL Credit Agreement includes customary representations, warranties and covenants, including, but not limited to, a financial covenants as to a minimum Fixed Charge Coverage Ratio (as defined in the ABL Credit Agreement). We were in compliance with the financial covenants of the ABL Facility as of March 31, 2026.

Our obligations under the ABL Credit Agreement are guaranteed by certain of our subsidiaries and are required to be guaranteed by certain of our later formed or acquired subsidiaries (collectively, the "Guarantors"). Our obligations under the ABL Credit Agreement are collateralized by substantially all of our and the Guarantors' assets. The ABL Agent, for itself and on behalf of the Lenders, has a first lien on accounts receivable and inventory.

The ABL Credit Agreement contains customary events of default relating to, among other things, payment defaults, breach of covenants, cross acceleration to material indebtedness, bankruptcy-related defaults, judgment defaults, and the occurrence of certain change of control events. If an event of default occurs, the lenders under the ABL Credit Agreement will be entitled to take various actions, including the termination of any undrawn commitments and the acceleration of amounts due under the ABL Credit Agreement.

*Sale-Leaseback Transactions*

In May 2025, we sold property for a sales price of $4.3 million and concurrent with the sale, entered into a 19-year lease agreement with the purchaser for the property. In March 2024, we sold three of our properties for an aggregate sales price of $16.9 million and concurrent with the sale, we entered into a 20-year lease agreement with the purchaser for these properties.

Since these lease agreements allow for us to exercise renewal options that extend for substantially all of the remaining economic life, we have the ability to maintain the risks and rewards of ownership. Because the transactions did not transfer control of the assets, they cannot be accounted for as sales under ASC 606. As a result, the properties remain on our Condensed Consolidated Balance Sheets and the non-land assets will continue to be depreciated over their remaining useful lives. The $21.2 million of total gross proceeds from these transactions were recognized as financing obligations as a component of long-

------

<u>[**Table of Contents**](#ic208c3c52e35488b93bc4cab94d51b11_7)</u>

term debt. The monthly lease payments, which increase 3.00% each year, are being amortized as principal payments and interest expense through 2044 based on a weighted average effective interest rate of 9.17%. We incurred $0.9 million in debt issuance costs related to these transactions, which is being amortized over the term of the debt.

In June and July 2025, we sold pieces of manufacturing equipment for an aggregate sales price of $2.7 million and entered into 3 to 5-year lease agreements with the purchaser for the equipment. In March 2024, we sold multiple pieces of manufacturing equipment for an aggregate sales price of $4.9 million. Concurrent with the sale, we entered into a 5-year lease agreement with the purchaser that includes a repurchase option for this equipment. In May 2024, we sold additional pieces of manufacturing equipment for an aggregate sales price of $3.4 million and entered into 5-year and 6-year lease agreements with the purchaser for the equipment. Since these lease agreements allow for us to exercise a purchase option, we have the ability to maintain the risks and rewards of ownership. Since the transactions did not transfer control of the assets, they cannot be accounted for as sales under ASC 606. As a result, the assets remain on our Condensed Consolidated Balance Sheets and will continue to be depreciated over their remaining useful lives. The $11.0 million of total gross proceeds from these transactions were recognized as a financing obligation as a component of long-term debt. The monthly lease payments are being amortized as principal payments and interest expense on a weighted average effective interest rate of 8.26%.

*International Loans*

We have fixed rate debt with various financial institutions in France, Poland and China, with maturity dates between 2026 and 2033. These loans, which were obtained to fund working capital and equipment purchases, had a weighted average interest rate of 2.20% at March 31, 2026.

**Note 9. Preferred Stock**

On March 22, 2021, we completed a private placement of 65,000 shares of newly designated Series D Perpetual Preferred Stock, with a par value of $0.01 per share (the "Series D Preferred Stock"), at a price of $1,000 per share. The Series D Preferred Stock has an initial liquidation preference of $1,000 per share and is redeemable at our option in cash at a redemption price equal to the liquidation preference then in effect. Series D Preferred Stock shares earn cash dividends at a rate of 10.0% per year, payable quarterly in arrears, accruing whether or not earned or declared. If no cash dividend is paid, then the liquidation preference per share effective on the dividend date increases to 12.0% per year. On March 22, 2026, the cash dividend rate and in-kind dividend rate increased by 2.5%, and will increase by 2.5% each year thereafter. Cash dividends are required beginning on September 30, 2027 and are limited based on terms and conditions of the Company's outstanding credit agreements.

The Series D Preferred Stock is classified as mezzanine equity, between liabilities and stockholders' equity, because certain features of the Series D Preferred Stock could require redemption of the Series D Preferred Stock upon a change of control event that is considered not solely within our control. For initial recognition, the Series D Preferred Stock was recognized at a discounted value, net of issuance costs and allocation to warrants and a bifurcated embedded derivative. The aggregate discount was amortized as a deemed dividend through March 22, 2026, which is the date the dividend rate increased to 14.5% per year. Deemed dividends adjust additional paid-in capital due to the absence of retained earnings.

In accordance with ASC 815-15, *Derivatives and Hedging - Embedded Derivatives,* certain features of the Series D Preferred Stock were bifurcated and accounted for as derivatives separately. Note 16 discusses the accounting for these features.

As of March 31, 2026, the carrying value of the Series D Preferred Stock shares was $117.8 million, which included $71.2 million of accumulated unpaid and deemed dividends. The following table presents the change in the Series D Preferred Stock carrying value during the three months ended March 31, 2026.

---

| | |
|:---|:---|
| Balance as of December 31, 2025 | $112409 |
| Accrual of in-kind dividends | 3452 |
| Amortization | 1986 |
| Balance as of March 31, 2026 | $117847 |

---

------

<u>[**Table of Contents**](#ic208c3c52e35488b93bc4cab94d51b11_7)</u>

**Note 10. Leases**

The following table contains supplemental cash flow information related to leases.

---

| | | |
|:---|:---|:---|
| | **Three Months Ended <br>March 31,** | **Three Months Ended <br>March 31,** |
| | **2026** | **2025** |
| Cash paid for amounts included in the measurement of lease liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;Operating cash flows used in operating leases | $2127 | $2158 |
| &nbsp;&nbsp;&nbsp;Operating cash flows used in finance leases | 116 | 133 |
| &nbsp;&nbsp;&nbsp;Financing cash flows used in finance leases | 1067 | 981 |
| Right-of-use assets obtained in exchange for new finance lease liabilities | 120 | 276 |

---

We recognized sublease income of $1.0 million and $1.0 million in the three months ended March 31, 2026 and 2025, respectively, which is recognized in the Other operating income, net line in the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss).

The following table presents finance lease-related assets and liabilities recorded on the balance sheet.

---

| | | | |
|:---|:---|:---|:---|
| | **Financial Statement Line Item** | **March 31, 2026** | **December 31, 2025** |
| Finance lease assets | Property, plant and equipment, net | 17498 | 18108 |
| Finance lease current liabilities | Other current liabilities | 4269 | 4163 |
| Finance lease non-current liabilities | Other non-current liabilities | 3057 | 4110 |
| Total finance lease liabilities |  | $7326 | $8273 |

---

**Note 11. Commitments and Contingencies**

*Brazil ICMS Tax Matter* 

Prior to the acquisition of Autocam Corporation ("Autocam") in 2014, Autocam's Brazilian subsidiary ("Autocam Brazil") received notification from the Brazilian tax authority regarding ICMS (state value added tax) tax credits claimed on intermediary materials (e.g., tooling and perishable items) used in the manufacturing process. The Brazilian tax authority notification disallowed state ICMS tax credits claimed on intermediary materials based on the argument that these items are not intrinsically related to the manufacturing processes. Autocam Brazil filed an administrative defense with the Brazilian tax authority arguing, among other matters, that it should qualify for an ICMS tax credit, contending that the intermediary materials are directly related to the manufacturing process.

We believe that we have substantial legal and factual defenses, and we continue to defend our interests in this matter vigorously. The matter encompasses several lawsuits filed with the Brazilian courts requesting declaratory actions that no tax is due or seeking a stay of execution on the collection of the tax. We have obtained multiple favorable decisions and one unfavorable decision. Although we anticipate a favorable resolution to the remaining matters, we can provide no assurances that we will be successful in achieving dismissal of all pending cases. The U.S. dollar amount that would be owed in the event of an unfavorable decision is subject to interest, penalties, and currency impacts and therefore is dependent on the timing of the decision. For the remaining open lawsuits, we currently believe the cumulative potential liability in the event of unfavorable decisions on all matters will be less than $2.0 million, inclusive of interest and penalties.

We are entitled to indemnification from the former shareholders of Autocam, subject to the limitations and procedures set forth in the agreement and plan of merger relating to the Autocam acquisition. Accordingly, we do not expect such losses, if any, to have a material impact on our business, operations or financial results.

*Other Legal Matters*

All other legal proceedings are of an ordinary and routine nature and are incidental to our operations. Management believes that such proceedings should not, individually or in the aggregate, have a material adverse effect on our business, financial condition, results of operations, or cash flows. In making that determination, we analyze the facts and circumstances of each case at least quarterly in consultation with our attorneys and determine a range of reasonably possible outcomes.

**Note 12. Income Taxes**

Our effective tax rate was (8.6)% and (16.8)% for the three months ended March 31, 2026 and 2025, respectively. The effective tax rate for the three months ended March 31, 2026 differs from the U.S. federal statutory tax rate of 21% primarily due to the accrual of tax on non-permanently reinvested unremitted earnings of foreign subsidiaries, and by limitation of the

------

<u>[**Table of Contents**](#ic208c3c52e35488b93bc4cab94d51b11_7)</u>

amount of tax benefit recorded for losses in certain jurisdictions where we believe it is more likely than not that a future tax benefit may not be realized.

**Note 13. Net Loss Per Common Share** 

The following table summarizes the computation of basic and diluted net loss per common share.

---

| | | |
|:---|:---|:---|
| | **Three Months Ended <br>March 31,** | **Three Months Ended <br>March 31,** |
| | **2026** | **2025** |
| Numerator: |  |  |
| Net loss | $(6828) | $(6685) |
| &nbsp;&nbsp;&nbsp;Adjustment for preferred stock cumulative dividends and deemed dividends | (5438) | (4407) |
| Numerator for basic and diluted net loss per common share | $(12266) | $(11092) |
| Denominator: |  |  |
| Weighted average common shares outstanding | 50386 | 49987 |
| &nbsp;&nbsp;&nbsp;Adjustment for participating securities | (2123) | (2372) |
| &nbsp;&nbsp;&nbsp;Adjustment for warrants outstanding (1) | 1439 | 1460 |
| Shares used to calculate basic and diluted net loss per share | 49702 | 49075 |
| Basic and diluted net loss per common share | $(0.25) | $(0.23) |

---

_______________________________

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) &nbsp;&nbsp;&nbsp;&nbsp;Outstanding warrants that are exercisable at an exercise price of $0.01 per share are included in shares outstanding for calculation of basic earnings per share (see Note 16).

The following table presents securities that could be potentially dilutive in the future that were excluded from the calculation of diluted net loss per common share because they had an anti-dilutive effect.

---

| | | |
|:---|:---|:---|
| | **Three Months Ended <br>March 31,** | **Three Months Ended <br>March 31,** |
| | **2026** | **2025** |
| Stock options | 74 | 168 |
| Warrants | 1370 | 1500 |
| Performance share units | 820 | 820 |
| Total antidilutive securities | 2264 | 2488 |

---

Stock options excluded from the calculations of diluted net loss per share have a per share exercise price ranging from $7.93 to $24.55 for the three months ended March 31, 2026. Warrants excluded from the calculation of diluted net loss per share have a per share exercise price of $11.03 (see Note 16). Performance share units are potentially dilutive when the related performance criterion has been met.

**Note 14. Share-Based Compensation**

The following table lists the components of share-based compensation expense by type of award, which is recognized in the Selling, general, and administrative expense line in the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss).

---

| | | |
|:---|:---|:---|
| | **Three Months Ended <br>March 31,** | **Three Months Ended <br>March 31,** |
| | **2026** | **2025** |
| Restricted stock | $485 | $550 |
| Performance share units | 316 | 289 |
| Share-based compensation expense | $801 | $839 |

---

------

<u>[**Table of Contents**](#ic208c3c52e35488b93bc4cab94d51b11_7)</u>

*Restricted Stock*

The following table presents the status of unvested restricted stock awards as of March 31, 2026, and activity during the three months then ended.

---

| | | |
|:---|:---|:---|
| | **Nonvested<br>Restricted<br>Shares** | **Weighted Average Grant-Date<br>Fair Value** |
| Unvested at January 1, 2026 | 2027 | $2.08 |
| &nbsp;&nbsp;Granted | 1088 | 1.23 |
| &nbsp;&nbsp;Vested | (452) | 2.69 |
| &nbsp;&nbsp;Forfeited | (6) | 2.55 |
| Unvested at March 31, 2026 | 2657 | $1.63 |

---

During the three months ended March 31, 2026, we granted 1,088,000 shares of restricted stock to non-executive directors, officers and certain other employees. The shares of these restricted stock awards vest pro-rata generally over three years for employees and over one year for non-executive directors. Total grant date fair value of restricted stock that vested in the three months ended March 31, 2026, was $1.2 million.

*Performance Share Units*

Performance Share Units ("PSUs") are a form of long-term incentive compensation awarded to executive officers and certain other key employees designed to directly align the interests of employees to the interests of our stockholders, and to create long-term stockholder value. The following table presents the status of unvested PSUs as of March 31, 2026, and activity during the three months then ended.

---

| | | |
|:---|:---|:---|
| | **Nonvested PSU Awards** | **Weighted Average Grant-Date<br>Fair Value** |
| Nonvested at January 1, 2026 | 3877 | $1.48 |
| &nbsp;&nbsp;&nbsp;Granted | 544 | 1.33 |
| &nbsp;&nbsp;&nbsp;Vested | (124) | 1.23 |
| Nonvested at March 31, 2026 | 4297 | $1.47 |

---

During the three months ended March 31, 2026, we granted 544,000 PSUs to certain executive officers, which vest, if at all, upon our achieving a specified relative total shareholder return, which will be measured against the total shareholder return of a specified index during the three-year performance period that ends December 31, 2028.

We estimated the grant date fair value of the PSU awards using the Monte Carlo simulation model, as the total shareholder return metric and changes in stock price are considered market conditions under ASC Topic 718, *Compensation – stock compensation*.

**Note 15. Accumulated Other Comprehensive Income (Loss)** 

The following tables present the components of accumulated other comprehensive income (loss).

---

| | |
|:---|:---|
| | **Foreign Currency Translation** |
| Balance as of December 31, 2025 | $(38579) |
| &nbsp;&nbsp;&nbsp;Other comprehensive income | 1547 |
| Balance as of March 31, 2026 | $(37032) |
| Balance as of December 31, 2024 | $(48167) |
| &nbsp;&nbsp;&nbsp;Other comprehensive income | 3125 |
| Balance as of March 31, 2025 | $(45042) |

---

**Note 16. Fair Value Measurements**

Fair value is an exit price representing the expected amount that an entity would receive to sell an asset or pay to transfer a liability in an orderly transaction with market participants at the measurement date. We followed consistent methods and assumptions to estimate fair values as more fully described in the 2025 Annual Report.

------

<u>[**Table of Contents**](#ic208c3c52e35488b93bc4cab94d51b11_7)</u>

*Embedded Derivatives*

In accordance with ASC 815-15, *Derivatives and Hedging - Embedded Derivatives*, certain features of our preferred stock and long-term debt were bifurcated and accounted for as derivatives separately.

In conjunction with an amendment to our 2021 Term Loan in 2023, we issued warrants to purchase up to 2.0 million shares of our common stock at an exercise price of $0.01 per share (the "2023 Warrants"). The 2023 Warrants were exercisable, in full or in part, at any time prior to June 30, 2033. The 2023 Warrants included anti-dilution adjustments in the event of certain future equity issuances, stock splits, stock dividends, combinations or similar events. As of March 31, 2026, all 2023 Warrants have been exercised with 1,455,000 being settled on a cashless basis during the three months ended March 31, 2026.

In conjunction with our placement of the Series B Preferred Stock in 2019, we issued warrants to purchase up to 1.5 million shares of our common stock (the "2019 Warrants"). The 2019 Warrants, are exercisable, in full or in part, at any time prior to December 11, 2026, at an exercise price of $11.03 per share, and are subject to anti-dilution adjustments in the event of future below market issuances, stock splits, stock dividends, combinations or similar events. During the three months ended March 31, 2026, a portion of the 2019 Warrants were cancelled resulting in a decrease of 285,000 exercisable shares.

The following table presents the change in the liability balance of the embedded derivatives during the three months ended March 31, 2026:

---

| | |
|:---|:---|
| Balance as of December 31, 2025 | $1868 |
| Change in fair value (1) | 245 |
| Settlements | (2110) |
| Balance as of March 31, 2026 | $3 |

---

_______________________________

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;&nbsp;&nbsp;&nbsp;Changes in the fair value are recognized in the Other expense (income), net line in the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss).

The following tables show the fair values of the embedded derivatives within the fair value hierarchy.

---

| | | |
|:---|:---|:---|
| **<u>March 31, 2026</u>** | **Quoted Prices in Active Markets for Identical Assets<br>(Level 1)** | **Significant Unobservable Inputs<br>(Level 3)** |
| Derivative liability - other current liabilities | $– $– $| 3 |

---

---

| | | | |
|:---|:---|:---|:---|
| **<u>December 31, 2025</u>** | **Quoted Prices in Active Markets for Identical Assets<br>(Level 1)** | **Significant Other Observable Inputs<br>(Level 2)** | **Significant Unobservable Inputs<br>(Level 3)** |
| Derivative liability - other non-current liabilities | $1861 | $– $| 7 |

---

The fair value of the 2023 Warrants and 2021 Warrants is determined using the observable market price of a share of our common stock, less the $0.01 per share exercise price (Level 1).

The fair value of the 2019 Warrants is determined using a valuation model that utilizes unobservable inputs to determine the probability that the 2019 Warrants will remain outstanding for future periods (Level 3). The probabilities resulted in a weighted average term of 0.8 years and 1.3 years as of March 31, 2026 and December 31, 2025, respectively.

*Fair Value Disclosures*

Our financial instruments that are subject to fair value disclosure consist of cash and cash equivalents, accounts receivable, accounts payable, and debt. As of March 31, 2026 and December 31, 2025, the carrying values of these financial instruments, except for debt, approximated fair value. The fair value of our debt was $153.6 million and $156.9 million, with a carrying amount of $170.4 million and $159.5 million, as of March 31, 2026 and December 31, 2025, respectively. The fair value of debt was calculated by discounting the future cash flows to its present value using prevailing market interest rates for debt with similar creditworthiness, terms and maturities (Level 3).

**Note 17. Plant Optimization Activities**

During the second half of 2024, we took specific steps to consolidate our footprint by identifying two manufacturing facilities to close due to volume rationalization which have reduced costs and improved operational efficiency. We ceased production activities at our Mobile Solutions plants in Juarez, Mexico and Dowagiac, Michigan in January 2025 and March 2025, respectively. In addition, we implemented operational and cost optimization actions to reduce indirect and overhead costs.

------

<u>[**Table of Contents**](#ic208c3c52e35488b93bc4cab94d51b11_7)</u>

In 2025, we completed the facility closures and organizational changes previously announced. In connection therewith, as stated in our 2025 Annual Report, we recognized $13.4 million in charges. All costs incurred have been recognized in the Mobile Solutions segment. We expect to recognize annual benefits of approximately $5.4 million.

The following is a summary of plant optimization reserve activity for the three months ended March 31, 2026:

---

| | |
|:---|:---|
| | **Severance and employee related** |
| Balance as of December 31, 2025 | $512 |
| &nbsp;&nbsp;Amounts paid | (9) |
| Balance as of March 31, 2026 | $503 |

---

*Voluntary Early Retirement Program*

During the three months ended March 31, 2026, we recognized $0.1 million related to an early retirement incentive program ("ERIP") that was open to certain U.S. employees that met specified age and service requirements, and who terminated employment in 2026. The estimated total cost of the ERIP, including costs recognized in 2025, is $0.5 million with all benefit payments expected to be made in 2026.

------

<u>[**Table of Contents**](#ic208c3c52e35488b93bc4cab94d51b11_7)</u>

**Item 2.&nbsp;&nbsp;&nbsp;&nbsp;Management's Discussion and Analysis of Financial Condition and Results of Operations**

*Management's Discussion and Analysis of Financial Condition and Results of Operations is intended to help the reader understand the results of operations and financial condition of NN, Inc. and its consolidated subsidiaries for the three months ended March 31, 2026. The financial information as of March 31, 2026, should be read in conjunction with the consolidated financial statements for the year ended December 31, 2025, contained in our Form 10-K for the year ended December 31, 2025 ("2025 Annual Report"), and the Condensed Consolidated Financial Statements included in this Quarterly Report.*

**Forward-Looking Statements** 

This Quarterly Report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), which are intended to be covered by the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and include this statement for purposes of complying with these safe harbor provisions. Forward-looking statements generally will be accompanied by words such as "anticipate," "believe," "could," "estimate," "expect," "forecast," "growth," "guidance," "intend," "may," "will," "possible," "potential," "predict," "project," "trajectory" or the negative of those terms, and similar expressions that convey uncertainty of future events or outcomes. Forward-looking statements involve a number of risks and uncertainties that are outside of management's control and that may cause actual results to be materially different from such forward-looking statements. Such factors include, among others, general economic conditions and economic conditions in the industrial sector; competitive influences; risks that current customers will commence or increase captive production; risks of capacity underutilization; quality issues; inflationary pressures and material changes in the cost or availability of raw materials, supply chain shortages and disruptions, the availability of labor and labor disruptions along the supply chain; our dependence on certain major customers, some of whom are not parties to long-term agreements (and/or are terminable on short notice); the impact of acquisitions and divestitures, as well as expansion of end markets and product offerings; our ability to hire or retain key personnel; the restrictions contained in our debt agreements; the level of our indebtedness and our ability to obtain financing at favorable rates, if at all, or to refinance existing debt as it matures; our ability to secure, maintain or enforce patents or other appropriate protections for our intellectual property; the impact of climate change on our operations; economic, social, political and geopolitical instability, military conflict, currency fluctuation, and other risks of doing business outside of the United States; uncertainty of government policies and actions in respect to global trade and tariffs, including the potential impacts of tariffs on the United States economy, the economy of other countries in which we conduct operations and our industry, cyber liability or potential liability for breaches of our or our service providers' information technology systems or business operations disruptions; and other risks and uncertainties set forth in documents filed, or to be filed, with the Securities and Exchange Commission (the "SEC"). For the reasons described above, the Company cautions against relying on any forward-looking statements, which should be read in conjunction with the sections entitled "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" included in our 2025 Annual Report, this Quarterly Report and any of the Company's subsequent filings made with the SEC. Any forward-looking statement speaks only as of the date of this Quarterly Report, and the Company undertakes no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise, except as required by law.

For additional information concerning such risk factors and cautionary statements, please see the sections titled "Item 1A. Risk Factors" in the 2025 Annual Report and this Quarterly Report.

**Overview**

NN, Inc., a Delaware corporation, is a diversified industrial company that combines advanced engineering and production capabilities with in-depth materials science expertise to design and manufacture high-precision components and assemblies for a variety of end markets on a global basis. As used in this Quarterly Report, the terms "NN," the "Company," "we," "our," or "us" refer to NN, Inc. and its subsidiaries.

**Factors That May Influence Results of Operations** 

We believe there are several important factors that have influenced, and we expect will continue to influence, our results of operations.

<u>Macroeconomic Conditions</u>

We continue to monitor the ongoing impacts of current macroeconomic and geopolitical events, including changing conditions from global trade negotiations and tariffs, inflationary cost pressures on metal, raw materials, and other manufacturing inputs, elevated interest rates, supply chain disruptions, and ongoing military conflicts.

Global trade negotiations continue to create volatility in the marketplace. New trade restrictions and/or increases in tariffs could have a material impact on our business, financial condition, or results of operations by increasing our input costs and decreasing demand, although the nature of those trade restrictions and tariffs remains unclear. Additionally, tariffs may

------

<u>[**Table of Contents**](#ic208c3c52e35488b93bc4cab94d51b11_7)</u>

increase the risk for elevated inflation more generally, which may drive an increase in other input costs and have made it more difficult to procure precious metals. In particular, prices for commodities and certain metals, including, but not limited to, steel, copper, and precious metals, have recently shown increased volatility. Significant price increases for these commodities and precious metals have, and could continue to have, an adverse effect on our liquidity and operating profits if we cannot timely mitigate the price increases by successfully sourcing lower cost commodities or precious metals or by passing the increased costs on to customers.

We cannot predict the future impact on our end-markets or input costs, including tariffs and their potential implications and ramifications, nor our ability to recover all cost increases, including the cost of raw materials, through pricing or the timing of such recoveries.

<u>Footprint Optimization</u>

During the second half of 2024, we identified two manufacturing facilities to close due to volume rationalization which have reduced costs and improved operational efficiency. During the first quarter of 2025, we ceased production activities at our Mobile Solutions plants in Juarez, Mexico and Dowagiac, Michigan. In addition, we implemented operational and cost optimization actions to reduce indirect and overhead costs. We continue to evaluate our global footprint, which may result in further consolidation actions to further improve our overall cost structure.

**Results of Operations**

*Three Months Ended March 31, 2026 compared to the Three Months Ended March 31, 2025* 

<u>Consolidated Results</u>

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended March 31,** | **Three Months Ended March 31,** | **Three Months Ended March 31,** |
| | **2026** | **2025** | **$ Change** |
| Net sales | $118452 | $105688 | $12764 |
| Cost of sales (exclusive of depreciation and amortization shown separately below) | 99031 | 91646 | 7385 |
| Selling, general, and administrative expense | 13294 | 11170 | 2124 |
| Depreciation and amortization | 9240 | 8774 | 466 |
| Other operating income, net | (1055) | (1113) | 58 |
| **Loss from operations** | (2058) | (4789) | 2731 |
| Interest expense | 5769 | 5194 | 575 |
| Other expense (income), net | 502 | (2169) | 2671 |
| Loss before provision for income taxes and share of net income from joint venture | (8329) | (7814) | (515) |
| Provision for income taxes | (717) | (1310) | 593 |
| Share of net income from joint venture | 2218 | 2439 | (221) |
| **Net loss** | $(6828) | $(6685) | $(143) |

---

*Net Sales*. Net sales increased by $12.8 million, or 12.1%, during the three months ended March 31, 2026, compared to the three months ended March 31, 2025, primarily due to the contribution of new business launches, higher precious metals pass-through pricing, higher volumes in certain areas and favorable foreign exchange effects of $3.1 million.

*Cost of Sales.* Cost of sales increased by $7.4 million, or 8.1%, during the three months ended March 31, 2026, compared to the three months ended March 31, 2025, primarily due to the increase in sales.

*Selling, General, and Administrative Expense.* Selling, general, and administrative expense increased by $2.1 million during the three months ended March 31, 2026, compared to the three months ended March 31, 2025, primarily due to payroll and benefits compensation expense related to an increase in bonus expense and medical benefits.

*Depreciation and amortization*. Depreciation and amortization increased by $0.5 million during the three months ended March 31, 2026, compared to the three months ended March 31, 2025, primarily due to the impact of capital expenditures placed in service in the current and prior year.

------

<u>[**Table of Contents**](#ic208c3c52e35488b93bc4cab94d51b11_7)</u>

*Interest Expense.* Interest expense increased by $0.6 million during the three months ended March 31, 2026, compared to the three months ended March 31, 2025, primarily due to an increase in average debt balances and interest rates. The increases are partially offset by a decrease in amortization of debt issuance costs and discount.

---

| | | |
|:---|:---|:---|
| | **Three Months Ended March 31,** | **Three Months Ended March 31,** |
| | **2026** | **2025** |
| Interest on debt | $5516 | $4405 |
| Amortization of debt issuance costs and discount | 249 | 716 |
| Capitalized interest | (213) | (211) |
| Other | 217 | 284 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total interest expense | $5769 | $5194 |

---

*Other Expense (Income), Net.* Other expense (income), net decreased by $2.7 million during the three months ended March 31, 2026, compared to the three months ended March 31, 2025, primarily due to noncash derivative mark-to-market loss recognized during the first quarter of 2026 compared to noncash derivative mark-to-market gain the first quarter of 2025.

*Provision for Income Taxes*. Our effective tax rate was (8.6)% for the three months ended March 31, 2026, compared to (16.8)% for the three months ended March 31, 2025. The rate for the three months ended March 31, 2026 was unfavorably impacted due to the accrual of tax on non-permanently reinvested unremitted earnings of foreign subsidiaries and by the limitation of the amount of tax benefit recorded for losses in certain jurisdictions where we believe it is more likely than not that a future tax benefit may not be realized.

*Share of Net Income from Joint Venture.* Share of net income from the Wuxi Weifu Autocam Precision Machinery Company, Ltd. joint venture (the "JV") decreased during the three months ended March 31, 2026, compared to the three months ended March 31, 2025. The JV, in which we own a 49% investment, recognized net sales of $32.2 million and $32.7 million for the three months ended March 31, 2026 and 2025, respectively.

<u>Results by Segment</u> 

MOBILE SOLUTIONS

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended March 31,** | **Three Months Ended March 31,** | **Three Months Ended March 31,** |
| | **2026** | **2025** | **$ Change** |
| Net sales | $63113 | $62244 | $869 |
| Loss from operations | $(2075) | $(2687) | $612 |

---

Net sales increased by $0.9 million, or 1.4%, during the three months ended March 31, 2026, compared to the three months ended March 31, 2025, primarily due to favorable growth in North America, South America, and Europe and foreign exchange effects of $2.6 million. These increases were partially offset by soft China volumes.

Loss from operations decreased by $0.6 million during the three months ended March 31, 2026, compared to the three months ended March 31, 2025, primarily related to improved operating performance, partially offset by increase in selling, general, and administrative costs.

POWER SOLUTIONS

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended March 31,** | **Three Months Ended March 31,** | **Three Months Ended March 31,** |
| | **2026** | **2025** | **$ Change** |
| Net sales | $55400 | $43508 | $11892 |
| Income from operations | $6297 | $3023 | $3274 |

---

Net sales increased by $11.9 million, or 27.3%, during the three months ended March 31, 2026 compared to the three months ended March 31, 2025, due to sales mix, an increase in precious metals pass-through pricing, higher volumes in certain areas and favorable foreign exchange effects of $0.5 million.

Income from operations increased by $3.3 million during the three months ended March 31, 2026 compared to the same period in the prior year, primarily due to a better sales mix and operating performance.

------

<u>[**Table of Contents**](#ic208c3c52e35488b93bc4cab94d51b11_7)</u>

**Changes in Financial Condition from December 31, 2025 to March 31, 2026** 

*Overview*

From December 31, 2025 to March 31, 2026, total assets increased by $12.6 million, primarily due to increases in accounts receivable, inventories and prepaid assets. The increases are partially offset by decreases in cash and cash equivalents, property, plant and equipment, right-of-use assets, and intangible assets.

From December 31, 2025 to March 31, 2026, total liabilities increased by $15.1 million, primarily due to increases in accrued salaries, wages and benefits, other current liabilities and long-term debt due to $10.0 million of proceeds from the Delayed Draw Term Loan (as described below). These increases were partially offset by a decrease in operating lease liabilities and other non-current liabilities.

Working capital, which consists of current assets less current liabilities, increased by $9.4 million, from December 31, 2025 to March 31, 2026. The change was primarily due to an increase in accounts receivable offset by increases in accounts payable, other current liabilities and accrued salaries, wages, and benefits.

*Cash Flows*

Cash used in operations was $8.6 million for the three months ended March 31, 2026, compared with $3.3 million for the three months ended March 31, 2025. The unfavorable change was primarily due to an increase in accounts receivable, inventories, and other operating assets, partially offset by change in other operating liabilities.

Cash used in investing activities decreased by $0.5 million during the three months ended March 31, 2026, compared with the three months ended March 31, 2025, due to a decrease in purchases of property, plant and equipment in 2026.

Cash provided by financing activities increased by $7.4 million during the three months ended March 31, 2026, compared with the three months ended March 31, 2025. The increase was primarily due to $10.0 million of proceeds from Delayed Draw Term Loan (as described below), offset by lower net proceeds from our asset backed credit facilities (as described below).

**Liquidity and Capital Resources** 

*Credit Facilities*

<u>Term Loan Facility</u> 

On April 16, 2025 (the "Closing Date"), we entered into a Term Loan Credit Agreement by and among the Company, the lenders from time to time party thereto (collectively, the "Lenders") and Alter Domus (US) LLC, as administrative agent (the "Term Loan Agent") for the Lenders (the "Term Loan Credit Agreement"). The Term Loan Credit Agreement establishes a new $128.0 million senior secured Term Loan Facility (the "Term Loan Facility") consisting of (i) a $118.0 million of term loan funded in full on the Closing Date (the "Closing Date Term Loans") and (ii) $10.0 million of delayed draw term loan commitments (any delayed draw term loans funded thereunder, the "Delayed Draw Term Loans", and together, with the Closing Date Term Loans, the "Term Loans"). As of March 31, 2026, we had $11.4 million of outstanding letters of credit issued under the ABL Facility and $30.7 million in undrawn commitments. The Term Loans mature on April 16, 2030. We used the proceeds from the Closing Date Term Loan to repay all of our outstanding obligations under our outstanding term loan facility (see Note 9 to the Consolidated Financial Statements in our 2025 Annual Report).

Under the Term Loan Credit Agreement, interest rates on the Term Loans are determined based on the type of Term Loan, the length of the interest period, and our Consolidated Net Leverage Ratio (as defined in the Term Loan Credit Agreement). The Term Loans currently bear interest at either: 1) one-month, three-month, or six-month term secured overnight finance rate ("SOFR") with a credit spread adjustment, subject to a 2.00% floor, plus an applicable margin ranging from 8.75% to 9.75% based on our Consolidated Net Leverage Ratio (as defined therein) ("Adjusted Term SOFR Rate Loans"); or 2) the greater of various benchmark rates, with certain adjustments, plus an applicable margin ranging from 7.75% to 8.75% based on our Consolidated Net Leverage Ratio ("Base Rate Loans"). For interest payments due before April 16, 2027, we may elect to pay a portion of interest in-kind ("PIK Election"), subject to a minimum cash interest of 5.25% for Adjusted Term SOFR Rate Loans and 4.25% for Base Rate Loans. The applicable margin increases by 0.50% on borrowings to which the PIK Election is made. At March 31, 2026, the Term Loans bore interest, including amounts we have elected to pay as PIK interest, based on one-month Adjusted Term SOFR, at 13.52%.

On January 29, 2026, we borrowed $10.0 million on the Delayed Draw Term Loans. As a result of borrowing the Delayed Draw Term Loans, the applicable margin for all Term Loans increased by 0.50%. Through January 29, 2026, we incurred a 1.00% commitment fee on undrawn amounts under the Delayed Draw, payable quarterly in arrears.

Subject to certain exceptions, we are required to make principal payments (i) annually that are calculated as a percentage, based on our Consolidated Net Leverage Ratio, of our Excess Cash Flow (as defined in the Term Loan Credit Agreement), (ii) Net Cash Proceeds (as defined in the Term Loan Credit Agreement) of certain non-ordinary course Dispositions (as defined in the

------

<u>[**Table of Contents**](#ic208c3c52e35488b93bc4cab94d51b11_7)</u>

Term Loan Credit Agreement) within 10 business days of receipt thereof, and (iii) Net Cash Proceeds from certain insurance events. We may voluntarily prepay the Term Loans, in whole or part without premium or penalty following April 16, 2027. If we would have voluntarily prepaid borrowings prior to April 16, 2026, we would have been subject to a prepayment premium equal to the present value at the prepayment date of (i) 2.00% of the outstanding principal amount of the Term Loans to be prepaid, plus (ii) all remaining scheduled interest payments due on such Term Loans through April 16, 2026 (excluding accrued but unpaid interest to, but not including, the prepayment date), computed using a discount rate equal to the Treasury Rate (determined as of the Business Day prior to such date of prepayment) plus 50 basis points. If we voluntarily prepay borrowings following April 16, 2026 and prior to April 16, 2027, we are subject to a prepayment premium equal to 2.00% of the principal amount prepaid.

The Term Loan Credit Agreement includes customary representations, warranties and covenants, including, but not limited to, certain financial covenants, such as maximum Consolidated Net Leverage Ratio and minimum Domestic Liquidity (as defined in the Term Loan Credit Agreement), subject, in the case of the Consolidated Net Leverage Ratio covenant, to certain equity cure rights. We were in compliance with the financial covenants of the Term Loan Facility as of March 31, 2026.

Our obligations under the Term Loan Credit Agreement are guaranteed by certain of our subsidiaries and are required to be guaranteed by certain of our later formed or acquired subsidiaries (collectively, the "Guarantors"). Our obligations under the Term Loan Credit Agreement are collateralized by substantially all of our and the Guarantors' assets. The Term Loan Agent, for itself and on behalf of the Lenders, has a first lien on all domestic assets, other than accounts receivable and inventory, and certain foreign assets and has a second lien on domestic accounts receivable and inventory.

The Term Loan Credit Agreement contains customary events of default relating to, among other things, payment defaults, breach of covenants, cross acceleration to material indebtedness, bankruptcy-related defaults, judgment defaults, and the occurrence of certain change of control events. If an event of default occurs, the lenders under the Term Loan Credit Agreement will be entitled to take various actions, including the termination of any undrawn commitments and the acceleration of amounts due under the Term Loan Credit Agreement.

The Term Loan Facility was issued at a $2.5 million discount and we capitalized an additional $0.7 million in debt issuance costs. In January 2026, we capitalized an additional $0.1 million in debt issuance costs as part of the borrowings under the Delayed Draw Term Loan. These costs are recorded as a direct reduction to the carrying amount of the associated long-term debt and amortized over the term of the debt.

*<u>ABL Facility</u>*

On December 30, 2024, we entered into a Revolving Credit and Security Agreement by and among the Company and PNC Bank National Association as lender and administrative agent (in such capacity, the "ABL Agent") (as amended from time to time, including by the First Amendment to Revolving Credit and Security Agreement, dated as of April 16, 2025, the "ABL Credit Agreement"). The ABL Credit Agreement established a new $50 million senior secured asset backed credit facility (the "ABL Facility") which provides for senior secured revolving loans ("Revolving Loan") in the amount of $50.0 million, and permits the issuance of letters of credit thereunder subject to a $15.0 million sublimit. The availability under the ABL Facility is limited by a borrowing base calculation derived from accounts receivable and inventory held in the United States, less customary reserves and other items. The final maturity date of the ABL Facility is the earlier of: 1) December 30, 2029; or 2) 91 days prior to the loan maturity date of the Term Loan Facility.

Under the ABL Facility, Revolving Loans bear interest as either 1) one, three or six month SOFR plus 1.50%, plus an adjustment of 0.10% ("Term SOFR Rate"); or 2) the highest of the base commercial lending rate of the lender or various benchmark rates plus an applicable margin of 0.50% or 1.00%, depending on the benchmark ("Alternative Base Rate"). At March 31, 2026, based on an Alternative Base Rate, the interest rate on outstanding borrowings under the ABL Facility was 7.25%. We incur a commitment fee of 0.25% for unused capacity under the ABL Facility and a 1.85% fee on the amount of letters of credit outstanding. We capitalized a total of $1.2 million in new debt issuance costs related to the ABL Facility.

As of March 31, 2026, we had $5.0 million outstanding borrowings under the ABL Facility, $11.4 million of outstanding letters of credit, and $30.7 million available for future borrowings under the ABL Facility.

The ABL Credit Agreement includes customary representations, warranties and covenants, including, but not limited to, a financial covenant as to a minimum Fixed Charge Coverage Ratio (as defined in the ABL Credit Agreement). We were in compliance with the financial covenants of the ABL Facility as of March 31, 2026.

Our obligations under the ABL Credit Agreement are guaranteed by certain of our subsidiaries and are required to be guaranteed by certain of our later formed or acquired subsidiaries (collectively, the "Guarantors"). Our obligations under the ABL Credit Agreement are collateralized by substantially all of our and the Guarantors' assets. The ABL Agent, for itself and on behalf of the Lenders, has a first lien on accounts receivable and inventory.

------

<u>[**Table of Contents**](#ic208c3c52e35488b93bc4cab94d51b11_7)</u>

The ABL Credit Agreement contains customary events of default relating to, among other things, payment defaults, breach of covenants, cross acceleration to material indebtedness, bankruptcy-related defaults, judgment defaults, and the occurrence of certain change of control events. If an event of default occurs, the lenders under the ABL Credit Agreement will be entitled to take various actions, including the termination of any undrawn commitments and the acceleration of amounts due under the ABL Credit Agreement.

*Sale Leaseback Transactions*

During 2025 and 2024, we entered into several sale-leaseback transactions and received a total of $21.2 million from the sale and leaseback of several properties. These financing obligations have a weighted average effective fixed interest rate of 9.17%, requires monthly payments and terminate in 2044. In addition, we received $11.0 million from the sale and leaseback of equipment. These financing obligations have a weighted average effective interest rate of 8.26%, require monthly payments and have a weighted average remaining term of 3.0 years.

*Working Capital Management* 

We manage our liquidity and working capital to fund our operations, meet debt service obligations, finance capital expenditures and fund other business initiatives. The cost of raw materials, primarily for steel, copper and precious metals is subject to price volatility due to tariffs, supply chain constraints and market supply and demand. A significant increase in the prices we pay for raw materials may cause our working capital needs to increase, which could reduce our liquidity and borrowing availability.

*Accounts Receivable Sales Programs* 

We participate in programs established by our customers and financial institutions which allow us to sell certain receivables from customers on a non-recourse basis to a third-party financial institution. In exchange, we receive payment on the receivables, less a discount, sooner than under the customary credit terms we have extended to customers. These programs allow us to improve working capital and cash flows at the same or lower interest rates as available on our ABL Facility. Our participation in these programs is based on our specific cash needs throughout the year, the discount charged to receive payment earlier, the length of the payment terms with our customers, as well being subject to limits in our ABL Facility and Term Loan Facility agreements.

*Other Receivables* 

In 2021, we filed a refund claim with the IRS as a result of the Coronavirus Aid, Relief, and Economic Security Act (the "CARES Act"). Including interest accrued on the initial refund amount, we have a $13.1 million tax refund receivable at March 31, 2026, which is being processed for refund at the IRS service center.

**Seasonality and Fluctuation in Quarterly Results**

General economic conditions impact our business and financial results, and certain businesses experience seasonal and other trends related to the industries and end markets that they serve. For example, European sales are often weaker in the summer months as customers slow production, and sales to original equipment manufacturers are often stronger immediately preceding and following the launch of new products. However, as a whole, we are not materially impacted by seasonality.

**Critical Accounting Estimates**

Our significant accounting policies, including the assumptions and judgments underlying them, are disclosed in Note 1 of the Notes to Consolidated Financial Statements included in the 2025 Annual Report. Our most critical accounting estimates are discussed in the Management's Discussion and Analysis of Financial Condition and Results of Operations included in the 2025 Annual Report. There have been no material changes to our significant accounting policies or critical accounting estimates during the three months ended March 31, 2026.

**Item 3. Quantitative and Qualitative Disclosures About Market Risk**

We are exposed to changes in financial market conditions in the normal course of business due to use of certain financial instruments as well as transacting business in various foreign currencies. To mitigate the exposure to these market risks, we have established policies, procedures, and internal processes governing the management of financial market risks. We are exposed to changes in interest rates primarily as a result of borrowing activities.

**Interest Rate Risk**

We are subject to interest rate risk due to our variable rate debt, which comprises a majority of our outstanding indebtedness. The nature and amount of borrowings may vary as a result of future business requirements, market conditions, and other factors. To manage interest rate risk, we have used, and may in the future use, interest rate swap agreements.

------

<u>[**Table of Contents**](#ic208c3c52e35488b93bc4cab94d51b11_7)</u>

At March 31, 2026, we had $131.8 million of principal outstanding under the Term Loan Facility without regard to capitalized debt issuance costs. A one-percent increase in one-month SOFR would have resulted in a net increase in interest expense of $1.3 million on an annualized basis.

During the three months ended March 31, 2026, based on the Alternative Base Rate, the average interest rate on outstanding borrowings under the ABL Facility was 7.25%.

**Foreign Currency Risk**

Translation of our operating cash flows denominated in foreign currencies is impacted by changes in foreign exchange rates. We invoice and receive payment from many of our customers in various other currencies. Additionally, we are party to third party and intercompany loans, payables, and receivables denominated in currencies other than the U.S. dollar. Various strategies to manage this risk are available to management, including producing and selling in local currencies and hedging programs. We did not hold a position in any foreign currency derivatives as of March 31, 2026.

**Item 4.&nbsp;&nbsp;&nbsp;&nbsp;Controls and Procedures**

**Disclosure Controls and Procedures**

Under the supervision and with the participation of management, including our Chief Executive Officer and Chief Financial Officer, we evaluated the effectiveness of disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) of the Exchange Act). Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of March 31, 2026, to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC's rules and forms, and that such information is accumulated and communicated to management, including the Chief Executive Officer and Chief Financial Officer, as appropriate, to allow for timely decisions regarding required disclosure.

**Changes in Internal Control Over Financial Reporting**

There were no changes in our internal control over financial reporting (as defined in the Exchange Act Rules 13a-15(f) and 15d-15(f)) that occurred during the fiscal quarter ended March 31, 2026, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

------

<u>[**Table of Contents**](#ic208c3c52e35488b93bc4cab94d51b11_7)</u>

**PART II. OTHER INFORMATION**

**Item 1.&nbsp;&nbsp;&nbsp;&nbsp;Legal Proceedings** 

As disclosed in Note 11 in the Notes to Condensed Consolidated Financial Statements included in this Quarterly Report, we are engaged in certain legal proceedings, and the disclosure set forth in Note 11 relating to legal proceedings is incorporated herein by reference.

**Item 1A.&nbsp;&nbsp;&nbsp;&nbsp;Risk Factors**

There have been no material changes to the risk factors disclosed in the 2025 Annual Report under Item 1A, "Risk Factors."

**Item 2. &nbsp;&nbsp;&nbsp;&nbsp;Unregistered Sales of Equity Securities and Use of Proceeds**

*Issuer Purchases of Equity Securities*

The following table provides information about purchases we made during the quarter ended March 31, 2026.

---

| | | | | |
|:---|:---|:---|:---|:---|
| Period | Total Number of<br>Shares Purchased <sup>(1)</sup> | Average Price Paid<br>Per Share | Total Number of<br>Shares Purchased<br>as Part of Publicly<br>Announced Plans<br>or Programs <sup>(1)</sup> | Maximum Number (or<br>Approximate Dollar Value)<br>of Shares That May Yet<br>Be Purchased Under the<br>Plan or Programs <sup>(1)</sup> |
| January 1, 2026 to January 31, 2026 |  |  |  |  |
| February 1, 2026 to February 28, 2026 |  |  |  |  |
| March 1, 2026 to March 31, 2026 | 68125 | 1.25 |  |  |
| Total | 68125 | $1.25 |  |  |

---

_______________________________

&nbsp;&nbsp;&nbsp;&nbsp;(1)Shares were withheld to pay for tax obligations due upon the vesting of share-based awards held by employees granted under the NN, Inc. Amended and Restated 2022 Omnibus Incentive Plan and prior plans (collectively the "Incentive Plans"). The Incentive Plans provide for the withholding of shares or units to satisfy income tax obligations. It does not specify a maximum number of shares or units that can be withheld for this purpose. These shares may be deemed to be "issuer purchases" of shares that are required to be disclosed pursuant to this Item.

**Item 3.&nbsp;&nbsp;&nbsp;&nbsp;Defaults Upon Senior Securities**

None.

**Item 4.&nbsp;&nbsp;&nbsp;&nbsp;Mine Safety Disclosures**

Not applicable.

**Item 5.&nbsp;&nbsp;&nbsp;&nbsp;Other Information**

*Adoption or Termination of Trading Arrangements*

During the quarter ended March 31, 2026, none of the Company's directors or executive officers adopted or terminated any Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement, as defined in Item 408 of Regulation S-K.

------

<u>[**Table of Contents**](#ic208c3c52e35488b93bc4cab94d51b11_7)</u>

**Item 6.&nbsp;&nbsp;&nbsp;&nbsp;Exhibits**

---

| | |
|:---|:---|
| **Exhibit Number** | **Description of Exhibit** |
| 3.1 | <u>[Restated Certificate of Incorporation of NN, Inc. (Filed as exhibit 3.1 to the Registrant's Registration Statement on Form S-3 on June 6, 2002 and incorporated herein by reference).](https://www.sec.gov/Archives/edgar/data/918541/000095016802001631/dex31.txt)</u> |
| 3.2 | <u>[Certificate of Amendment to Restated Certificate of Incorporation of NN, Inc. (Declassification) (Filed as Exhibit 3.1 to the Registrant's Current Report on Form 8-K filed on May 20, 2019 and incorporated herein by reference).](https://www.sec.gov/Archives/edgar/data/918541/000119312519151712/d750456dex31.htm)</u> |
| 3.3 | <u>[Certificate of Amendment to Restated Certificate of Incorporation of NN, Inc. (Share Increase) (Filed as Exhibit 3.2 to the Registrant's Current Report on Form 8-K filed on May 20, 2019 and incorporated herein by reference).](https://www.sec.gov/Archives/edgar/data/918541/000119312519151712/d750456dex32.htm)</u> |
| 3.4 | <u>[Amended and Restated By-Laws of NN, Inc. (Filed as Exhibit 3.1 to the Registrant's Current Report on Form 8-K filed on January 20, 2023 and incorporated herein by reference).](https://www.sec.gov/Archives/edgar/data/918541/000091854123000004/amendedandrestatedbylaws20.htm)</u> |
| 31.1 | <u>[Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as amended.](exhibit3112026-q1.htm)</u> |
| 31.2 | <u>[Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as amended.](exhibit3122026-q1.htm)</u> |
| 32.1\* | <u>[Certification of Principal Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](exhibit3212026-q1.htm)</u> |
| 32.2\* | <u>[Certification of Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](exhibit3222026-q1.htm)</u> |
| 101.INS | XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document) |
| 101.SCH | XBRL Taxonomy Extension Schema Document |
| 101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document |
| 101.LAB | XBRL Taxonomy Extension Label Linkbase Document |
| 101.PRE | XBRL Taxonomy Extension Presentation Linkbase Document |
| 101.DEF | XBRL Taxonomy Extension Definition Linkbase Document |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |

---

\*&nbsp;&nbsp;&nbsp;&nbsp;This certification is being furnished solely to accompany this quarterly report on Form 10-Q pursuant to 18 U.S.C. Section 1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Registrant, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

------

<u>[**Table of Contents**](#ic208c3c52e35488b93bc4cab94d51b11_7)</u>

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | |
|:---|:---|
| | NN, Inc. |
| | (Registrant) |
| Date: May 6, 2026 | /s/ Harold C. Bevis |
|  | Harold C. Bevis |
|  | President, Chief Executive Officer and Director |
|  | (Principal Executive Officer) |
|  | (Duly Authorized Officer) |
| Date: May 6, 2026 | /s/ Christopher H. Bohnert |
|  | Christopher H. Bohnert |
|  | Senior Vice President and Chief Financial Officer |
|  | (Principal Financial and Accounting Officer) |
|  | (Duly Authorized Officer) |

---

## Exhibit 31.1

**Exhibit 31.1**

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO RULES 13a-14(a) AND 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED

I, Harold C. Bevis, certify that:

1)I have reviewed this quarterly report on Form 10-Q of NN, Inc.;

2)Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3)Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4)The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of the annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5)The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
| Date: May 6, 2026 | /s/ Harold C. Bevis |
| | Harold C. Bevis |
| | President, Chief Executive Officer and Director |
| | (Principal Executive Officer) |

---

## Exhibit 31.2

**Exhibit 31.2**

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO RULES 13a-14(a) AND 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED

I, Christopher H. Bohnert, certify that:

1)I have reviewed this quarterly report on Form 10-Q of NN, Inc.;

2)Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3)Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4)The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of the annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5)The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
| Date: May 6, 2026 | /s/ Christopher H. Bohnert |
| | Christopher H. Bohnert |
| | Senior Vice President and Chief Financial Officer |
| | (Principal Financial Officer) |

---

## Exhibit 32.1

**Exhibit 32.1**

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT

TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of NN, Inc. (the "Company") on Form 10-Q for the quarterly period ended March 31, 2026, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned, in the capacity and date indicated below, hereby certifies pursuant to Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, (the "Exchange Act") and 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge: (1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act, and (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the periods indicated.

---

| | |
|:---|:---|
| Date: May 6, 2026 | /s/ Harold C. Bevis |
| | Harold C. Bevis |
| | President, Chief Executive Officer and Director |
| | (Principal Executive Officer) |

---

## Exhibit 32.2

**Exhibit 32.2**

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT

TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of NN, Inc. (the "Company") on Form 10-Q for the quarterly period ended March 31, 2026, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned, in the capacity and date indicated below, hereby certifies pursuant to Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, (the "Exchange Act") and 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge: (1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act, and (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the periods indicated.

---

| | |
|:---|:---|
| Date: May 6, 2026 | /s/ Christopher H. Bohnert |
| | Christopher H. Bohnert |
| | Senior Vice President and Chief Financial Officer |
| | (Principal Financial Officer) |

---

<br>